257 related articles for article (PubMed ID: 18209724)
1. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
de Lima M; McMannis J; Gee A; Komanduri K; Couriel D; Andersson BS; Hosing C; Khouri I; Jones R; Champlin R; Karandish S; Sadeghi T; Peled T; Grynspan F; Daniely Y; Nagler A; Shpall EJ
Bone Marrow Transplant; 2008 May; 41(9):771-8. PubMed ID: 18209724
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
4. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice.
Peled T; Landau E; Mandel J; Glukhman E; Goudsmid NR; Nagler A; Fibach E
Exp Hematol; 2004 Jun; 32(6):547-55. PubMed ID: 15183895
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of ex vivo expanded cord blood.
Shpall EJ; Quinones R; Giller R; Zeng C; Baron AE; Jones RB; Bearman SI; Nieto Y; Freed B; Madinger N; Hogan CJ; Slat-Vasquez V; Russell P; Blunk B; Schissel D; Hild E; Malcolm J; Ward W; McNiece IK
Biol Blood Marrow Transplant; 2002; 8(7):368-76. PubMed ID: 12171483
[TBL] [Abstract][Full Text] [Related]
6. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.
Jaroscak J; Goltry K; Smith A; Waters-Pick B; Martin PL; Driscoll TA; Howrey R; Chao N; Douville J; Burhop S; Fu P; Kurtzberg J
Blood; 2003 Jun; 101(12):5061-7. PubMed ID: 12595310
[TBL] [Abstract][Full Text] [Related]
9. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
[TBL] [Abstract][Full Text] [Related]
10. Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation.
Stiff PJ; Montesinos P; Peled T; Landau E; Goudsmid NR; Mandel J; Hasson N; Olesinski E; Glukhman E; Snyder DA; Cohen EG; Kidron OS; Bracha D; Harati D; Ben-Abu K; Freind E; Freedman LS; Cohen YC; Olmer L; Barishev R; Rocha V; Gluckman E; Horowitz MM; Eapen M; Nagler A; Sanz G
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1463-1470. PubMed ID: 29477778
[TBL] [Abstract][Full Text] [Related]
11. Cord-blood engraftment with ex vivo mesenchymal-cell coculture.
de Lima M; McNiece I; Robinson SN; Munsell M; Eapen M; Horowitz M; Alousi A; Saliba R; McMannis JD; Kaur I; Kebriaei P; Parmar S; Popat U; Hosing C; Champlin R; Bollard C; Molldrem JJ; Jones RB; Nieto Y; Andersson BS; Shah N; Oran B; Cooper LJ; Worth L; Qazilbash MH; Korbling M; Rondon G; Ciurea S; Bosque D; Maewal I; Simmons PJ; Shpall EJ
N Engl J Med; 2012 Dec; 367(24):2305-15. PubMed ID: 23234514
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
[TBL] [Abstract][Full Text] [Related]
13. Low rate of infusional toxicity after expanded cord blood transplantation.
Bear AS; Hanley PJ; Bosque DM; Cruz CR; Kaur I; Liu H; Kebriaei P; Hosing C; Rezvani K; Oran B; De Lima MJ; Bollard CM; Shpall EJ
Cytotherapy; 2014 Aug; 16(8):1153-7. PubMed ID: 24582458
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.
McNiece IK; Almeida-Porada G; Shpall EJ; Zanjani E
Exp Hematol; 2002 Jun; 30(6):612-6. PubMed ID: 12063029
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
16. Increased expansion and differentiation of cord blood products using a two-step expansion culture.
McNiece I; Kubegov D; Kerzic P; Shpall EJ; Gross S
Exp Hematol; 2000 Oct; 28(10):1181-6. PubMed ID: 11027837
[TBL] [Abstract][Full Text] [Related]
17. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN
Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070
[TBL] [Abstract][Full Text] [Related]
18. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells.
Peled T; Landau E; Prus E; Treves AJ; Nagler A; Fibach E
Br J Haematol; 2002 Mar; 116(3):655-61. PubMed ID: 11849228
[TBL] [Abstract][Full Text] [Related]
19. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
[TBL] [Abstract][Full Text] [Related]
20. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells.
Peled T; Glukhman E; Hasson N; Adi S; Assor H; Yudin D; Landor C; Mandel J; Landau E; Prus E; Nagler A; Fibach E
Exp Hematol; 2005 Oct; 33(10):1092-100. PubMed ID: 16219531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
